RAC 5.44% $1.65 race oncology ltd

All I can do is a range which states while exact figures, rather...

  1. 204 Posts.
    lightbulb Created with Sketch. 111
    All I can do is a range which states while exact figures, rather indicative. If the company is sold < $20 / share very disappointed, $21 to $40 / share disappointed. $41 to around $70 / share kind of OK can't complain, $71 to $100 / share happy, > $100 / share over the moon. I personally believe based on Bisantrene's history, recent data and potentials based on information from public sources, no of shares, company's management with DT at the helm if the clinical trials are at Stage 2 and all current assumptions (and hopes) validated, these prices could be real. Some of you may think I am irrealistic and delusional, I don't care just state what I think, whether it is right or wrong.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.65
Change
-0.095(5.44%)
Mkt cap ! $281.0M
Open High Low Value Volume
$1.78 $1.78 $1.62 $285.9K 170.1K

Buyers (Bids)

No. Vol. Price($)
1 16759 $1.65
 

Sellers (Offers)

Price($) Vol. No.
$1.69 12047 1
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.